Winship Cancer Institute Cancer Center Support Grant
Project Number2P30CA138292-14
Former Number3P30CA138292-13W1
Contact PI/Project LeaderRAMALINGAM, SURESH S
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
OVERALL
The mission of Winship Cancer Institute of Emory University (Winship) is to discover cures for cancer and
inspire hope. Winship is the only NCI-designated comprehensive cancer center in Georgia, the eighth most
populous state in the United States, with the second highest Black population in the country, and a growing
Hispanic population. Winship is comprised of 179 members who are national leaders in cancer research, from
31 departments and four schools across Emory University. Winship members form a strong collaborative
research community organized around four research programs supported by nine shared resources. During the
reporting period (2017-2021), members published 2,454 cancer relevant manuscripts (35% collaborative within
Winship and 75% with investigators at outside institutions). Members were supported by a total of $64M in peer-
reviewed cancer-relevant funding and $26.7M non peer-reviewed funding (as of December 31, 2021). Accruals
to interventional treatment trials increased by 23% and to Phase I trials by 34% (2017-2021) compared to the
prior five year time period (2012-2016). Winship has successfully received program project level funding
including a lung cancer SPORE award from the NCI in 2019 (P50CA217691), the myeloma Specialized Center
for Research (SCOR) from the Lymphoma and Leukemia Society in 2020, and a new inter-programmatic P01
for lung cancer research, all targeting high priority cancers in Winship’s catchment area. Research conducted
by Winship has directly contributed to FDA approval of new anti-cancer agents, first-in-human clinical trials, new
NCTN and ETCTN clinical trials (Phase I-III), and health care policy changes in the state of Georgia. Winship’s
strong COE efforts, guided by bi-directional communication with community partners, address several important
themes including tobacco control, HPV vaccination, promoting health literacy, reducing cancer disparities, cancer
screening in individuals living with HIV disease and promoting legislation that impacts the catchment area. Under
the leadership of Executive Director, Suresh Ramalingam, MD, and his senior leadership team, Winship aims
to: (1) conduct transformative research; (2), accelerate the translation of Winship member discoveries, (3) reduce
the burden of cancer in its catchment area, and (4) promote education, training and mentorship. Winship will
pursue these aims through its strong leadership team, robust infrastructure, exceptional institutional commitment,
ongoing community partnerships, and the recently formulated strategic plan for 2022-2026.
Public Health Relevance Statement
PROJECT NARRATIVE
WINSHIP CANCER INSTITUTE OF EMORY UNIVERSITY
CANCER CENTER SUPPORT GRANT
As the only NCI-designated comprehensive cancer center in Georgia, Winship Cancer Institute of Emory
University (Winship) serves as the primary institution for cancer care, research, training, and education for the
state. Winship's mission is to discover cures for cancer and inspire hope. Research conducted by Winship has
directly contributed to FDA approval of new anti-cancer agents, first-in-human clinical trials, new national clinical
trials and health care policy changes in the state of Georgia. Winship aims to: (1) conduct transformative
research; (2) accelerate the translation of Winship member discoveries; (3) reduce the burden of cancer in its
catchment area; and (4) promote education, training, and mentorship.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccelerationAddressAreaAwardBasic ScienceBlack PopulationsCancer BurdenCancer Center Support GrantCancer health equityCatchment AreaClinicalClinical SciencesClinical TrialsCommunicationCommunitiesCommunity OutreachComprehensive Cancer CenterCountryDiagnosisDiseaseEarly Therapeutic-Clinical Trials NetworkEducationEducation and OutreachFosteringFundingGrowthHIVHealthHealth PolicyHealth PromotionHispanic PopulationsHuman Papilloma Virus VaccinationIndividualInfrastructureInstitutionInterventionInvestmentsLeadershipMalignant NeoplasmsMalignant neoplasm of lungManuscriptsMentorshipMissionMultiple MyelomaPatientsPeer ReviewPhasePopulation SciencesPublishingQuality of lifeReportingResearchResearch PersonnelResource SharingResourcesRiskRuralSchoolsScienceScreening for cancerSocietiesSpecialized CenterStatutes and LawsStrategic PlanningTimeTrainingTraining and EducationTranslational ResearchTranslationsUnderrepresented PopulationsUnderserved PopulationUnited StatesUniversitiesanticancer researchcancer carecancer health disparityclinical carecommunity engagementcommunity organizationscommunity partnershipequity, diversity, and inclusionexperiencefirst-in-humanhealth literacyimprovedinnovationleukemia/lymphomamembernovel anticancer drugphase I trialprogramstobacco controltreatment trialtumor immunology
No Sub Projects information available for 2P30CA138292-14
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P30CA138292-14
Patents
No Patents information available for 2P30CA138292-14
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P30CA138292-14
Clinical Studies
No Clinical Studies information available for 2P30CA138292-14
News and More
Related News Releases
No news release information available for 2P30CA138292-14
History
No Historical information available for 2P30CA138292-14
Similar Projects
No Similar Projects information available for 2P30CA138292-14